- Q1 2024 TG Therapeutics Inc Earnings Call TranscriptMay 01, 2024Earnings
- Q4 2023 TG Therapeutics Inc Earnings Call TranscriptFeb 28, 2024€16.3 (+26.22%)Earnings
- TG Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2024
- Q3 2023 TG Therapeutics Inc Earnings Call TranscriptNov 01, 2023€9.66 (+48.52%)Earnings
- Q2 2023 TG Therapeutics Inc Earnings Call TranscriptAug 01, 2023€9.92 (-44.80%)Earnings
- TG Therapeutics Inc at Jefferies Healthcare Conference TranscriptJun 07, 2023
- TG Therapeutics Inc at Bank of America Global Healthcare Conference TranscriptMay 09, 2023
- Q1 2023 TG Therapeutics Inc Earnings Call TranscriptMay 01, 2023Earnings
- Q4 2022 TG Therapeutics Inc Earnings Call TranscriptFeb 28, 2023Earnings
- TG Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2023
- TG Therapeutics Inc BRIUMVI Call TranscriptDec 29, 2022
- Q3 2022 TG Therapeutics Inc Earnings Call TranscriptNov 10, 2022€7.42 (+35.40%)Earnings
- Q2 2022 TG Therapeutics Inc Earnings Call TranscriptAug 08, 2022€6.03 (-3.08%)Earnings
- TG Therapeutics Inc at B Riley Neuro & Ophthalmology Conference (Virtual) TranscriptApr 28, 2022
- TG Therapeutics Inc Update Call TranscriptApr 18, 2022
- Q4 2021 TG Therapeutics Inc Earnings Call TranscriptMar 01, 2022€9.01 (+5.19%)Earnings
- TG Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 10, 2022
- TG Therapeutics Inc Regulatory Updates TranscriptNov 30, 2021
- TG Therapeutics Inc at B Riley Fall Growth Biotech Best Ideas Series (Virtual) TranscriptNov 11, 2021
- Q3 2021 TG Therapeutics Inc Earnings Call TranscriptNov 04, 2021€29.84 (+6.84%)Earnings
- TG Therapeutics Inc ECTRIMS Investor & Analyst Event TranscriptOct 14, 2021
- TG Therapeutics Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) TranscriptSep 27, 2021
- TG Therapeutics Inc to Discuss Phase 1 U2 + Venetoclax Data Call TranscriptSep 20, 2021
- TG Therapeutics Inc at H C Wainwright Global Investment Conference (Virtual) TranscriptSep 13, 2021
- Q2 2021 TG Therapeutics Inc Earnings Call TranscriptAug 02, 2021€22.69 (-23.88%)Earnings
- TG Therapeutics Inc at Ladenburg Thalmann Virtual Healthcare Conference TranscriptJul 14, 2021
- TG Therapeutics Inc at Raymond James Human Health Innovation Conference (Virtual) TranscriptJun 22, 2021
- TG Therapeutics Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 08, 2021
- Q1 2021 TG Therapeutics Inc Earnings Call TranscriptMay 10, 2021€31.68 (-3.97%)Earnings
- TG Therapeutics Inc ULTIMATE I & II Phase 3 Investor & Analyst Webcast TranscriptApr 16, 2021
- Q4 2020 TG Therapeutics Inc Earnings Call TranscriptMar 02, 2021€37.29 (+0.47%)Earnings
- TG Therapeutics Inc Announces UKONIQ (umbralisib) FDA Approval Conference Call TranscriptFeb 08, 2021
- TG Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2021
- TG Therapeutics Inc Announces Positive Topline Results from the ULTIMATE I & II Phase 3 Studies Conference Call TranscriptDec 10, 2020
- TG Therapeutics Inc at Jefferies Virtual London Healthcare Conference TranscriptNov 17, 2020
- TG Therapeutics Inc ASH Abstract Release Conference Call TranscriptNov 05, 2020
- Q2 2020 TG Therapeutics Inc Earnings Call TranscriptAug 10, 2020€16.22 (-6.80%)Earnings
- TG Therapeutics Inc Annual Shareholders Meeting TranscriptJun 18, 2020
- TG Therapeutics Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 11, 2020
- TG Therapeutics Inc to Discuss UNITY-CLL Phase 3 Trial Conference Call TranscriptMay 05, 2020
- Q4 2019 TG Therapeutics Inc Earnings Call TranscriptMar 03, 2020€12.01 (+0.38%)Earnings
- TG Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 16, 2020
- TG Therapeutics, Inc. - Shareholder/Analyst Call TranscriptDec 10, 2019
- Q3 2019 TG Therapeutics Inc Earnings Call TranscriptNov 12, 2019€6.93 (-4.15%)Earnings
- TG Therapeutics, Inc. - Special Call TranscriptOct 28, 2019
- Q2 2019 TG Therapeutics Inc Earnings Call TranscriptAug 09, 2019€6 (+2.74%)Earnings
- Q1 2019 TG Therapeutics Inc Earnings Call TranscriptMay 10, 2019€7.06 (-0.70%)Earnings
- TG Therapeutics, Inc. - Special Call TranscriptApr 01, 2019
- TG Therapeutics, Inc. - Special Call TranscriptFeb 28, 2019
TG Therapeutics Inc Announces UKONIQ (umbralisib) FDA Approval Conference Call Transcript
Greetings, and welcome to the TG Therapeutics FDA Approval Conference Call and Webcast. (Operator Instructions) As a reminder, this conference is being recorded. (Operator Instructions) I would now like to turn the call over to Jenna Bosco, Senior Vice President of Corporate Communications. Please go ahead.
Welcome, everyone, and thank you all for joining us. I'm Jenna Bosco, and with me today to discuss the U.S. Food and Drug Administration's approval of umbralisib, now called UKONIQ, are Michael Weiss, our Executive Chairman and Chief Executive Officer; Dr. Owen O'Connor, our Chief Scientific Officer; and Adam Waldman, our Chief Commercialization Officer.
Mike will begin today's call by providing some introductory comments and context around Friday's FDA approval of UKONIQ for patients with relapsed/refractory marginal zone lymphoma and follicular lymphoma. Owen will review the label as well as the clinical data supporting the approval, and Adam will discuss our
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)